Your browser doesn't support javascript.
loading
Intensity Modulated Radiation Therapy Plus Etoposide/Cisplatin for Patients With Limited Advanced Unresectable Thymic Epithelial Tumors: A Prospective Phase 2 Study.
Fan, Xing-Wen; Yang, Yu; Wang, Hong-Bing; Xu, Yin; Kang, Mei; Xie, Li-Yi; Li, Ling; Fang, Wen-Tao; Zhao, Kuai-Le; Chen, Hai-Quan; Xiang, Jia-Qing; Ung, Yee C; Wong, C Shun; Jiang, Guo-Liang; Wu, Kai-Liang.
Affiliation
  • Fan XW; Department of Radiation Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Yang Y; Department of Radiation Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Wang HB; Department of Radiation Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Xu Y; Department of Radiation Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Kang M; Clinical Research Center, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Xie LY; Department of Radiation Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Li L; Department of Radiation Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Fang WT; Department of Thoracic Surgery, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, China.
  • Zhao KL; Department of Radiation Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Chen HQ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Thoracic Surgery, Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Xiang JQ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Thoracic Surgery, Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Ung YC; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Wong CS; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Jiang GL; Department of Radiation Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Radiation Oncology, Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai
  • Wu KL; Department of Radiation Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: wukailiang@aliyun.com.
Int J Radiat Oncol Biol Phys ; 107(1): 98-105, 2020 05 01.
Article in En | MEDLINE | ID: mdl-31987968
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymus Neoplasms / Cisplatin / Neoplasms, Glandular and Epithelial / Radiotherapy, Intensity-Modulated / Etoposide Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2020 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymus Neoplasms / Cisplatin / Neoplasms, Glandular and Epithelial / Radiotherapy, Intensity-Modulated / Etoposide Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2020 Type: Article Affiliation country: China